Roth/MKM Starts Gain Therapeutics (GANX) at Buy
Tweet Send to a Friend
(Updated - December 6, 2024 8:42 AM EST)
Roth/MKM analyst Boobalan Pachaiyappan initiates coverage on Gain Therapeutics (NASDAQ: GANX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Roth/MKM analyst Boobalan Pachaiyappan initiates coverage on Gain Therapeutics (NASDAQ: GANX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
